PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-4

  1. 42 Posts.
    lightbulb Created with Sketch. 11

    The Benjamin Button approval process?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.